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Purpose/Objective: The biogenic amines putrescine (Put), histamine
(His), spermidine (Spd), N-acetyl putrescine (NAP), N-acetyl sper-
midine (NAS), dopamine (Dop), epinephrine (Epi), norepinephrine
(NE) and spermine (Spm) are a group of naturally occurring com-
pounds exerting a large number of biological effects.
This study was commenced to elucidate the role of biogenic amines
as possible diagnostic markers for three autoimmune diseases: Diabetes
mellitus, Chronic urticaria, and Hashimoto’s thyroiditis.
Materials and methods: This study involved 20 patients with Diabetes
mellitus, 20 patients with Chronic urticaria, eight patients with
Hashimoto’s thyroiditis, and 20 healthy volunteers. We precipitated
serum proteins using 0.4 M HClO4. At pH 8.0 we performed
derivatization with dansyl-chloride. 50 ll of prepared serum samples
were injected into LC/DAD, in conditions of gradient elution, on C18
column. Commercially available Put, His, Spd, NAP, NAS, Dop, Epi,
NE, and Spm were dissolved in different concentrations in ultra pure
water; treated in the same way as serum samples and injected into LC.
Calibration curves were made by plotting peak area values against the
respective concentrations of standards. The qualitative analysis was
done using the method of retention time, and quantitative analysis
using external calibration. The recovery study was carried out using
real serum sample from healthy control, by spiking techniques.
Results: Retention times were 6.6 min for NAS, 8.8 min for NAP,
9.1 min for Put, 10.1 min for His, 13.2 min for Spd, 13.9 min for NE,
14.7 min for Epi, 14.9 min for Dop, and 15.4 min for Spm,
respectively. Obtained data showed excellent linearity of calibration
curves for Put, His, Spd, NAP, NAS, Dop, Epi, NE, and Spm.
Compared to controls, His levels in Diabetes mellitus patients were
statistically higher; in Chronic urticaria patients levels of Put and His
were lower; Spd, NE and Epi levels were enhanced; Put was statistically
lower and Spd higher in Hashimoto’s thyroiditis patients. Chronic
urticaria patients were the only in whose serum NE was found. NAP,
NAS, Dop, and Spm were under limits of detection.
Conclusions: Preliminary results from this study showed diverse
distribution of investigated biogenic amines indicating different
activation of metabolic pathways controlling biogenic amine biosyn-
thesis and degradations in analyzed autoimmune diseases.
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Purpose/Objective: The purpose of the present research was to
determine the levels of IL-1a, IL-1b, TNF-a, MMP-3 and MMP-8 in
gingival crevicular fluid (GCF) of subjects with chronic periodontitis
before and after non surgical treatment.
Materials and methods: Clinical measurements were carried out in 11
patients diagnosed with chronic periodontitis and 11 periodontally
healthy controls. The clinical indexes evaluated were: gingival index
(GI), plaque index (PI), bleeding on probing (BOP), probing depth
(PD) and attachment loss (AL). The measurements were taken at six
sites per tooth in all teeth in each subject. GCF samples were taken
from one tooth per quadrant, and the levels of these mediators were
measured using an ELISA test.
Results: A statistically significant difference (P < 0.05) was observed in
all the clinical parameters between patients and control group before and
after periodontal treatment. Correlations between levels of mediators
with the clinical parameters were not observed. Statistically significant
differences were found between patients and control group in relation
with levels of inflammatory mediators (P < 0.05) before and after
treatment. The levels of IL-1a, IL1-b, TNF-a, MMP-3 and MMP-8
decreased in 44.2%, 48.35%, 53.28%, 62.16% y 34.03% respectively.
Conclusions: Periodontal therapy reduced the levels of the inflam-
matory mediators evaluated in this study, which were significantly
associated with the severity of periodontal disease. This research was
supported by CDCH PG: 10-00-7070-2007.
P1590
Measuring autoantibodies against IL-17F and IL-22 in autoimmune
polyedocrine sydnrome type I
B. E. V. Oftedal,* A. Meager, E. S. Husebye & A. S. B. Wolff*
*Endocrinology, Institute of Medicine, Bergen, Norway, Biotherapeutics,
The National Institute for Biological Standards and Control, South
Mimms, UK, Endocrinology, Institute of Medicine, Haukeland Univer-
sity Hospital, Bergen, Norway
Purpose/Objective: Patients with autoimmune polyendocrine syn-
drome type I (APS I) have at least two of the three disease components
adrenal insufficiency, hypoparathyroidism and chronic mucocutane-
ous candidiasis. Various other organ-specific autoimmune manifesta-
tions are common, as well as a number of ectodermal symptoms. The
underlying cause of APS I is mutations in the gene encoding the
autoimmune regulator protein AIRE. Deficiency of this protein leads
to loss of immunologic tolerance and release of autoreactive T-cells
from thymus into the periphery.
Patients frequently develop high titers of autoantibodies against
molecular targets in their affected organs. The pathological role of
these antibodies is unknown, but they have become important markers
for APS I and other autoimmune conditions. Autoantibodies against
interleukin (IL) -17A, IL-17F and IL-22 have recently been described in
patients with APS I, and their presence is reported to be highly
correlated to chronic mucocutaneous candidiasis (CMC). The aim of
this study was to develop a robust high-throughput radioligand
binding assays (RLBA) measuring IL-17F and IL-22 antibodies, and to
compare them with current enzyme-linked immunosorbent assays
(ELISA) of IL-17F and IL-22; moreover to correlate the presence of
these antibodies to the presence of CMC.
Materials and methods: A total of five RLBAs were developed based
on IL-17F and IL-22 monomers and homo- or hetero dimers. As these
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